{"transactions":[{"id":4634616,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-10-02T16:00:24.000Z","date":"2026-10-01","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.92,"value":18400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"62,500 of the shares represents unvested restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027."}],"balance_after":420000,"source":{"system":"sec-edgar","filing":"0001171843-26-006349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184326006349/ownership.xml","form_type":"4"}},{"id":4626652,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-09-25T12:01:13.000Z","date":"2026-09-24","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.14,"value":2850.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"62,500 of the shares represents unvested restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001171843-26-006235","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184326006235/ownership.xml","form_type":"4"}},{"id":796900,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-04-30T20:00:48.000Z","date":"2026-04-29","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.89,"value":28350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"62,500 of the shares represents unvested restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027."}],"balance_after":397500,"source":{"system":"sec-edgar","filing":"0001171843-26-002894","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184326002894/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-29"}},{"id":797963,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-04-29T20:58:36.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":1.89,"value":28350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"62,500 of the shares represents unvested restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027."}],"balance_after":397500,"source":{"system":"sec-edgar","filing":"0001171843-26-002834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184326002834/ownership.xml","form_type":"4"}},{"id":951650,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:32:59.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":435000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest over 48 substantially equal monthly installments starting February 2, 2026."}],"balance_after":435000,"derivative":{"exercise_price":5.17,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":435000},"source":{"system":"sec-edgar","filing":"0001171843-26-000056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184326000056/ownership.xml","form_type":"4"}},{"id":951649,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:32:59.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":5.17,"value":323125.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first vesting on January 2, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"62,500 of the shares represents unvested restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027."}],"balance_after":382500,"source":{"system":"sec-edgar","filing":"0001171843-26-000056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184326000056/ownership.xml","form_type":"4"}},{"id":1175654,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2025-04-08T13:25:57.000Z","date":"2025-04-07","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.42,"value":28400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.43 per share. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above."}],"balance_after":320000,"source":{"system":"sec-edgar","filing":"0001171843-25-002084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184325002084/ownership.xml","form_type":"4"}},{"id":1269703,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T22:11:11.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting March 11, 2025."}],"balance_after":200000,"derivative":{"exercise_price":3.65,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001171843-25-000829","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000117184325000829/ownership.xml","form_type":"4"}},{"id":2982098,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-13T16:38:22.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable with respect to 25% of the shares on the first anniversary date of grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient is in the continuous employ of the Issuer through each such respective vesting date."}],"balance_after":3000,"derivative":{"exercise_price":4.07,"expiration_date":"2030-11-11","underlying":"Common Stock, $.005 Par Value","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001505148-20-000026","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/806517/000150514820000026/edgar.xml","form_type":"4"}},{"id":2982097,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2020-11-13T16:38:22.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 25% of the shares on the first anniversary date of the grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date."}],"balance_after":25866,"source":{"system":"sec-edgar","filing":"0001505148-20-000026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000150514820000026/edgar.xml","form_type":"4"}},{"id":3160193,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2020-05-06T19:21:02.000Z","date":"2020-05-04","kind":"tax_withholding","acquired":false,"shares":399,"price":5.75,"value":2294.25,"ownership":{"direct":true},"balance_after":15866,"source":{"system":"sec-edgar","filing":"0001505148-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000150514820000002/edgar.xml","form_type":"4"}},{"id":3537166,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2019-05-07T15:10:42.000Z","date":"2019-05-03","kind":"tax_withholding","acquired":false,"shares":154,"price":10.6,"value":1632.4,"ownership":{"direct":true},"balance_after":16265,"source":{"system":"sec-edgar","filing":"0001373894-19-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/806517/000137389419000038/edgar.xml","form_type":"4"}},{"id":3537165,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2019-05-07T15:10:42.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that are to be settled solely in shares of Common Stock.  The units vest with respect to 25% of the shares on the first anniversary date of grant, and with respect to an additional 25% on each of the three anniversary dates thereafer, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date."}],"balance_after":16419,"source":{"system":"sec-edgar","filing":"0001373894-19-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000137389419000038/edgar.xml","form_type":"4"}},{"id":3543290,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2019-05-02T15:37:18.000Z","date":"2019-04-30","kind":"tax_withholding","acquired":false,"shares":301,"price":11.6,"value":3491.6,"ownership":{"direct":true},"balance_after":12919,"source":{"system":"sec-edgar","filing":"0001373894-19-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000137389419000021/edgar.xml","form_type":"4"}},{"id":3598474,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2019-03-13T15:48:35.000Z","date":"2019-03-12","kind":"sale","acquired":false,"shares":1412,"price":15.06,"value":21264.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.93 to $15.25, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":13220,"source":{"system":"sec-edgar","filing":"0001373894-19-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/806517/000137389419000015/edgar.xml","form_type":"4"}},{"id":3598473,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2019-03-13T15:48:35.000Z","date":"2019-03-11","kind":"sale","acquired":false,"shares":7645,"price":15.11,"value":115515.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.30, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":14632,"source":{"system":"sec-edgar","filing":"0001373894-19-000015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000137389419000015/edgar.xml","form_type":"4"}},{"id":3921214,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2018-05-23T15:50:32.000Z","date":"2018-05-22","kind":"sale","acquired":false,"shares":1879,"price":19.99,"value":37561.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.96 to $20.00, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":22277,"source":{"system":"sec-edgar","filing":"0001739481-18-000025","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/806517/000173948118000025/edgar.xml","form_type":"4"}},{"id":3921213,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2018-05-23T15:50:32.000Z","date":"2018-05-21","kind":"sale","acquired":false,"shares":3013,"price":20.14,"value":60681.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.39, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":24156,"source":{"system":"sec-edgar","filing":"0001739481-18-000025","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000173948118000025/edgar.xml","form_type":"4"}},{"id":3939902,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2018-05-10T10:43:38.000Z","date":"2018-05-08","kind":"tax_withholding","acquired":false,"shares":282,"price":20.21,"value":5699.22,"ownership":{"direct":true},"balance_after":27169,"source":{"system":"sec-edgar","filing":"0001739481-18-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000173948118000022/edgar.xml","form_type":"4"}},{"id":3944868,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2018-05-07T15:45:27.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that are to be settled solely in shares of Common Stock.  The units vest with respect to 25% of the shares on the first anniversary date of grant, and with respect to an additional 25% on each of the three anniversary dates thereafer, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date."}],"balance_after":27451,"source":{"system":"sec-edgar","filing":"0001739481-18-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000173948118000014/edgar.xml","form_type":"4"}},{"id":3950559,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2018-05-02T15:17:13.000Z","date":"2018-04-30","kind":"tax_withholding","acquired":false,"shares":286,"price":21.06,"value":6023.16,"ownership":{"direct":true},"balance_after":25451,"source":{"system":"sec-edgar","filing":"0001033284-18-000049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000103328418000049/edgar.xml","form_type":"4"}},{"id":4305658,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2017-05-25T15:30:40.000Z","date":"2017-05-23","kind":"tax_withholding","acquired":false,"shares":276,"price":21.04,"value":5807.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an Additional 81 Shares acquired since May 8, 2017 under the Company's Dividend Reinvestment Plan"}],"balance_after":25447,"source":{"system":"sec-edgar","filing":"0001240679-17-000018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000124067917000018/edgar.xml","form_type":"4"}},{"id":4329228,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2017-05-09T16:27:44.000Z","date":"2017-05-08","kind":"tax_withholding","acquired":false,"shares":284,"price":20.6,"value":5850.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an additional 515 shares acquired since September 10, 2015 under the Company's Dividend Reinvestment Plan."}],"balance_after":25642,"source":{"system":"sec-edgar","filing":"0001505148-17-000018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000150514817000018/edgar.xml","form_type":"4"}},{"id":4332517,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-05T16:41:39.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable with respect to 25% of the shares on the first anniversary date of grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient remains in the continuous employ of the Issuer through each such respective vesting date."}],"balance_after":12000,"derivative":{"exercise_price":18.87,"expiration_date":"2027-05-04","underlying":"Common Stock, $.005 Par Value","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001505148-17-000011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000150514817000011/edgar.xml","form_type":"4"}},{"id":4336359,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2017-05-03T15:27:34.000Z","date":"2017-05-01","kind":"tax_withholding","acquired":false,"shares":311,"price":18.56,"value":5772.16,"ownership":{"direct":true},"balance_after":25411,"source":{"system":"sec-edgar","filing":"0001505148-17-000007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000150514817000007/edgar.xml","form_type":"4"}},{"id":4547817,"issuer":{"id":85009,"kind":"organization","name":"PSYCHEMEDICS CORP","symbol":"PMD"},"owners":[{"id":50579,"kind":"person","name":"Lerner Neil","position":1,"cik":"0001505148","reported_name":"Lerner Neil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Finance"}}],"security":"Common Stock, $.005 Par Value","published_at":"2016-11-21T15:32:29.000Z","date":"2016-11-18","kind":"sale","acquired":false,"shares":3000,"price":24.75,"value":74250.0,"ownership":{"direct":true},"balance_after":25722,"source":{"system":"sec-edgar","filing":"0001505148-16-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806517/000150514816000005/edgar.xml","form_type":"4"}}]}